WBSCR22 and TRMT112 Synergistically Suppress Cell Proliferation, Invasion and Tumorigenesis in Pancreatic Cancer Via Transcriptional Regulation of ISG15

Overview

Journal Int J Oncol

Specialty Oncology

Date 2022 Jan 28

PMID 35088887

Authors

Aamir Ali Khan

Hua Huang

Yue Zhao

Huan Li

Ruining Pan

Sijia Wang

Xinhui Liu

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer (PC) is one of the most aggressive and devastating types of cancer owing to its poor prognosis and deadly characteristics. It is well established that aberrations in the expression of key regulatory genes, namely tumor suppressors and oncogenes, predispose patients to progression and metastasis of PC. Upregulation of Williams‑Beuren syndrome chromosomal region 22 (WBSCR22) expression, a ribosomal biogenesis factor, has been reported in multiple types of human cancer. However, the role of WBSCR22 and its underlying mechanism in PC have not been well investigated. In the present study, the tumor suppressive role of WBSCR22 was reported in PC for the first time; the results indicated that WBSCR22 overexpression (OE) significantly suppressed cellular proliferation, migration, invasion and tumorigenesis and . RNA‑sequencing analysis revealed that WBSCR22 negatively regulated the transcription of interferon‑stimulated gene 15 (ISG15) downstream, which is a ubiquitin‑like modifier protein involved in metabolic and proteasome degradation pathways, while the antitumor function of WBSCR22‑OE could be rescued by ISG15 OE. In addition, the oncogenic role of ISG15 was further confirmed in PC; its upregulation promoted the proliferation, migration, invasion and tumorigenesis of PC. Furthermore, WBSCR22 and its cofactor tRNA methyltransferase activator subunit 11‑2 (TRMT112) functioned synergistically in PC, and concurrent ectopic OE of WBSCR22 and TRMT112 further promoted the tumor suppressive potential of WBSCR22 in PC. Collectively, the findings indicated that WBSCR22 played an important role in PC development and that the WBSCR22/ISG15 axis may provide a novel therapeutic strategy for PC treatment.

Citing Articles

N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential.

Wu Q, Fu X, Liu G, He X, Li Y, Ou C J Hematol Oncol. 2025; 18(1):12.

PMID: 39881381 PMC: 11780989. DOI: 10.1186/s13045-025-01665-7.

Functions of METTL1/WDR4 and QKI as m7G modification - related enzymes in digestive diseases.

Zhou W, Yi Y, Cao W, Zhong X, Chen L Front Pharmacol. 2025; 15():1491763.

PMID: 39850560 PMC: 11754259. DOI: 10.3389/fphar.2024.1491763.

RNA modifications in cancer.

Wu H, Chen S, Li X, Li Y, Shi H, Qing Y MedComm (2020). 2025; 6(1):e70042.

PMID: 39802639 PMC: 11718328. DOI: 10.1002/mco2.70042.

A novel nomogram model for lung adenocarcinoma subtypes based on RNA-modification regulatory genes.

Chen X, Zhang M, Ji X, Li R, Wang Q, Qu Y Heliyon. 2024; 10(12):e33106.

PMID: 39022104 PMC: 11252981. DOI: 10.1016/j.heliyon.2024.e33106.

Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies.

Yuan W, Zhang R, Lyu H, Xiao S, Guo D, Zhang Q Cell Death Discov. 2024; 10(1):327.

PMID: 39019857 PMC: 11254935. DOI: 10.1038/s41420-024-02097-x.

References

Stefanska B, Cheishvili D, Suderman M, Arakelian A, Huang J, Hallett M . Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets. Clin Cancer Res. 2014; 20(12):3118-32. DOI: 10.1158/1078-0432.CCR-13-0283. View

Burks J, Reed R, Desai S . Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective. Oncotarget. 2015; 6(9):7221-31. PMC: 4466680. DOI: 10.18632/oncotarget.3372. View

Liger D, Mora L, Lazar N, Figaro S, Henri J, Scrima N . Mechanism of activation of methyltransferases involved in translation by the Trm112 'hub' protein. Nucleic Acids Res. 2011; 39(14):6249-59. PMC: 3152332. DOI: 10.1093/nar/gkr176. View

Jangani M, Poolman T, Matthews L, Yang N, Farrow S, Berry A . The methyltransferase WBSCR22/Merm1 enhances glucocorticoid receptor function and is regulated in lung inflammation and cancer. J Biol Chem. 2014; 289(13):8931-46. PMC: 3979408. DOI: 10.1074/jbc.M113.540906. View

Burks J, Reed R, Desai S . ISGylation governs the oncogenic function of Ki-Ras in breast cancer. Oncogene. 2013; 33(6):794-803. DOI: 10.1038/onc.2012.633. View

Sun J, Yan J, Qiao H, Zhao F, Li C, Jiang J . Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation. Oncogene. 2019; 39(3):546-559. DOI: 10.1038/s41388-019-0992-2. View

Reich N, Evans B, Levy D, Fahey D, KNIGHT Jr E, Darnell Jr J . Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A. 1987; 84(18):6394-8. PMC: 299082. DOI: 10.1073/pnas.84.18.6394. View

Hung Y, Hsu M, Chen L, Hung W, Pan M . Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication. J Clin Med. 2019; 8(6). PMC: 6617267. DOI: 10.3390/jcm8060903. View

Ferrari M, Stagi S . Oxidative Stress in Down and Williams-Beuren Syndromes: An Overview. Molecules. 2021; 26(11). PMC: 8197362. DOI: 10.3390/molecules26113139. View

10.

Zhou M, Chen F, Chen H, Wan X, Zhou X, Fang Q . ISG15 inhibits cancer cell growth and promotes apoptosis. Int J Mol Med. 2016; 39(2):446-452. DOI: 10.3892/ijmm.2016.2845. View

11.

Cao W, Chen H, Yu Y, Li N, Chen W . Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021; 134(7):783-791. PMC: 8104205. DOI: 10.1097/CM9.0000000000001474. View

12.

Garcia B, Horie M, Kojima S, Makino A, Tomonaga K . BUD23-TRMT112 interacts with the L protein of Borna disease virus and mediates the chromosomal tethering of viral ribonucleoproteins. Microbiol Immunol. 2021; 65(11):492-504. DOI: 10.1111/1348-0421.12934. View

13.

Khan A, Liu X, Yan X, Tahir M, Ali S, Huang H . An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression. Cancer Metastasis Rev. 2021; 40(1):245-272. DOI: 10.1007/s10555-020-09952-0. View

14.

DCunha J, KNIGHT Jr E, Haas A, Truitt R, Borden E . Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A. 1996; 93(1):211-5. PMC: 40208. DOI: 10.1073/pnas.93.1.211. View

15.

Ounap K, Leetsi L, Matsoo M, Kurg R . The Stability of Ribosome Biogenesis Factor WBSCR22 Is Regulated by Interaction with TRMT112 via Ubiquitin-Proteasome Pathway. PLoS One. 2015; 10(7):e0133841. PMC: 4516353. DOI: 10.1371/journal.pone.0133841. View

16.

Wang L, Leng J, Li Z, Yan L, Gou P, Tang F . Clinical and genetic characteristics of two cases with Williams-Beuren syndrome. Transl Pediatr. 2021; 10(6):1743-1747. PMC: 8261582. DOI: 10.21037/tp-21-161. View

17.

Gu T, He H, Zhang Y, Han Z, Hou G, Zeng T . Trmt112 gene expression in mouse embryonic development. Acta Histochem Cytochem. 2012; 45(2):113-9. PMC: 3365302. DOI: 10.1267/ahc.11047. View

18.

Held T, Basler M, Knobeloch K, Groettrup M . Evidence for an involvement of the ubiquitin-like modifier ISG15 in MHC class I antigen presentation. Eur J Immunol. 2020; 51(1):138-150. DOI: 10.1002/eji.202048646. View

19.

Tiedemann R, Zhu Y, Schmidt J, Shi C, Sereduk C, Yin H . Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome. Cancer Res. 2011; 72(3):757-68. PMC: 3622723. DOI: 10.1158/0008-5472.CAN-11-2781. View

20.

Ounap K, Kasper L, Kurg A, Kurg R . The human WBSCR22 protein is involved in the biogenesis of the 40S ribosomal subunits in mammalian cells. PLoS One. 2013; 8(9):e75686. PMC: 3781059. DOI: 10.1371/journal.pone.0075686. View